Clinical Diagnostics

Featured COVID-19 Products

Bio-Rad is contributing to the advancement of COVID-19 testing and research with the latest Platelia SARS-CoV-2 Total Antibody Assay for the screening of antibodies to the novel coronavirus, SARS-CoV-2, our SARS-CoV-2 Standards for COVID-19 research testing, and our ddPCR testing systems for absolute quantification.

• 

  Coronavirus Ag Rapid Test Cassette (Swab)

  The Coronavirus Ag Rapid Test provides a quick and easy tool for detecting nucleocapsid protein from SARS-CoV-2 in the early stages of COVID-19 infection, from nasal swab or nasopharyngeal swab specimens. This CE-assay uses highly sensitive monoclonal antibodies, offering a robust level of performance. A separate external qualitative quality control kit is available for order to help validate new test kits, test new lots, train new operators, etc.

  Contact a Sales Specialist

• 

  BioPlex 2200 SARS-CoV-2 IgG Panel

  The BioPlex 2200 SARS-CoV-2 IgG Panel provides a multiplexed, semi-quantitative method for the screening and differentiation of IgG antibodies to SARS-CoV-2 receptor-binding domain (RBD), spike 1 (S1), spike 2 (S2), and nucleocapsid (N) proteins. Excellent linearity and precision allows for confidence in the BioPlex 2200 SARS-CoV-2 IgG Panel results and longitudinal analyses of COVID-19 patient samples.

  Contact a Sales Specialist

• 

  Platelia SARS-CoV-2 Total Ab Assay

  The Platelia SARS-CoV-2 Total Ab assay is designed to screen for total anti-nucleocapsid antibodies (IgM, IgA and IgG) to coronavirus SARS-CoV-2, the virus associated with COVID-19. The assay provides high specificity, no cross-reactivity and high sensitivity. It is CE-IVD validated available for in vitro diagnostic testing by professionals in a laboratory environment only.

  Contact a Sales Specialist

• 

  Platelia SARS-CoV-2 Total Ab Assay

  The Platelia SARS-CoV-2 Total Ab assay is designed to screen for total anti-nucleocapsid antibodies (IgM, IgA and IgG) to coronavirus SARS-CoV-2, the virus associated with COVID-19. The assay provides high specificity, no cross-reactivity and high sensitivity. It is CE-IVD validated available for in vitro diagnostic testing by professionals in a laboratory environment only.

  Contact a Sales Specialist

• 

  VIROTROL SARS-CoV-2 and VIROCLEAR SARS-CoV-2

  These unassayed ready-to-use, liquid quality controls are formulated from human plasma to test for total IgG/IgM and IgG antibodies to SARS-CoV-2 and are available in three separate classes specifically designed to challenge the assay cutoff of a broad range of methodologies.

  Contact a Sales Specialist